- Neogen (NASDAQ: NEOG) reported strong financial results, surpassing analyst expectations for both earnings per share and revenue.
- The company announced a strategic equity investment and collaboration with Hinalea Imaging Corp. to advance digital food safety tools.
- Despite the positive earnings, Neogen’s stock experienced a significant decline following an FDA warning concerning a recalled product, prompting potential securities-law investigations.
Neogen (NASDAQ: NEOG), a leading food and animal safety company, announced its latest earnings report before the market opened on October 6, 2026. The company reported earnings per share of $0.08, surpassing the analyst estimate of $0.05. This key financial metric, earnings per share, represents the company’s profit divided by its outstanding shares.
Revenue for the period reached $222.80 million, significantly exceeding the $208.20 million estimate by $14.60 million. Prior to the official announcement, analysts, as highlighted by Zacks Investment Research, had projected revenue of $208.09 million and earnings per share of $0.05, underscoring Neogen’s strong financial performance.
In a strategic move, Neogen also unveiled a collaboration and equity investment in Hinalea Imaging Corp., as reported by Business Wire. This partnership aims to develop advanced digital imaging tools for enhanced food safety solutions. The specific investment amount was not disclosed by Neogen.
Despite the positive earnings beat, Neogen faced a significant product quality concern. Shares experienced a notable decline of more than 7% in a single trading session following an FDA warning regarding HYCOAT, a recalled equine product from the Neogen Vet line. This development has led to law firm Levi & Korsinsky investigating potential securities-law claims on behalf of Neogen shareholders, raising investor concerns.
